| Name | Title | Contact Details |
|---|
Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.
Our mission is simple. Deliver the most high-performance skincare and haircare solutions powered by the latest clinical advances to transform the look of your skin and hair. At the center of every formula is patented, proprietary NIA-114 technology that supercharges StriVectin`s clinically proven, award winning products.
Health Professionals and Allied Employees - AFT/AFL-CIO is a Emerson, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MediSystem Technologies Inc. is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Braswell'S Chateau Villa is a Redlands, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.